INVESTORS

As an ambitious technology company, we work exclusively with investors that share our passion and vision. We want to work with individuals who bring additional value aside from funding, who have ideas and enthusiasm for a new digital age, who are flexible, fast and results-oriented.

Technology is already a part of our lives, but it can do more: We believe in the power of technology to help people live their healthiest lives.

INTELLECTUAL PROPERTY

Suisse Life Science Group’s IP includes:

  • Proprietary genetic panels, methods, and life science knowledge base
  • Patent-pending proprietary
    bioinformatics algorithms
  • Trademarks and patents.

For example, the following Swiss patent filings:

  • Methods for generating and screening metabolic and genetic diversity in order to prevent aging-related diseases
  • Bioinformatics data mining platform for targeted knowledge discovery and precision medicine
  • Metabolic matching-diet and dynamic food environment reorganization for active weight management and disease prevention
  • Methods for identifying a subject’s macronutrient sensitivity
  • Methods for identifying a subject’s micronutrient sensitivity
  • Multi-tier approach and integrated genomic services to prevent celiac disease and genetic food sensitivities
  • Methods and algorithms to generate and adapt in real-time a healthy weight management plan (macronutrient ratio, micronutrient needs, preventive nutrition, metabolic exercise needs, epigenetic chrono-nutrition) to fit the subject’s biological age and lifestyle.

RELEVANT INVESTORS

invest in digital health
DeepMind
Ventures
Ltd
49.56%
GDTRE Srl
17.30%
Gandini’s
family
10.78%
Bonsai
Capital
20.00%
Tamburi
Investment
Partners S.p.A.
2.36%

Suisse Life Science Group Shareholders Nationality

DeepMind Ventures Ltd.49.56%
GDTRE Srl17.30%
Gandini’s family10.78%
Bonsai Capital20.00%
Tamburi Investment Partners S.p.A.2.36%

Suisse Life Science Group Shareholders Nationality

DeepMind Ventures Ltd. is an investment company representing Suisse Life Science founder and top management.

Bonsai Capital Ltd. is a principal investor in early-stage Life Science companies, focused on startups developing medicines, platform technologies, and diagnostics.

GDTRE S.r.l. is a privately held Italian company and investor in the lifestyle, fashion, and food industries.

Tamburi Investment Partners S.p.A. is an independent Italian investment-merchant bank specializing in “excellent” small-to mid-sized companies (€1.2bn direct investments and club deals) – listed on FTSE MIB.

Suisse Life Science Group’s shareholders are completed by HNWI, prime investors in private equity.